Essity Reports Stable Q3 and Agrees to Acquire Kenvue Brazil Feminine Care Business
Essity reported resilient profitability, strong cash flow, higher prices versus Q2 and ongoing cost savings. Its acquisition of Kenvue’s Brazil feminine care business is subject to approvals; a strategic review of Consumer Tissue continues.
Essity reported stable third-quarter results, with resilient profitability and strong cash flow. Prices were higher than in Q2, and cost savings continued. The company also agreed to acquire Kenvue’s feminine care business in Brazil, subject to approvals. Essity said its strategic review of Consumer Tissue is ongoing.